HerbClinical dose · 100–200mg/day (Pycnogenol or equivalent standardised extract)Onset · The cognitive studies ran 8–12 weeks

Maritime Pine Bark Extract

Name: Maritime Pine Bark Extract — Human Clinical Effect Matrix
Creator: The Nootropic Lab
License: https://creativecommons.org/licenses/by/4.0/

A 2014 Pycnogenol study (Belcaro et al.) in healthy professionals aged 35–55 reported small but significant cognitive improvements and a 30.4% drop in plasma free radicals after 12 weeks at 150mg/day — but it was a non-randomized product-evaluation registry study, not an RCT. A 2011 controlled (non-randomized) study in students (Luzzi et al.) reported better attention, memory and exam scores over 8 weeks. Both come from the same Irvine3 Labs / Chieti-Pescara author group, which has published numerous Pycnogenol studies; Pycnogenol is a Horphag Research trademark, and these trials are widely reported as industry-supported, though no sponsor is disclosed in the abstracts. The independent 2020 Cochrane review rated the evidence for every pine bark outcome it assessed as very low certainty. A 2025 network meta-analysis ranked Pycnogenol highly for mild cognitive impairment but cautioned about heterogeneity.

By The Nootropic Lab editorial teamUpdated Oct 14, 20268 min read✓ Fact-checked

Evidence reviewed: Sep 28, 2026

Mechanism of action

Maritime Pine Bark Extract (Pinus pinaster) contains proanthocyanidins — potent polyphenol antioxidants that cross the blood-brain barrier. It works via three pathways: (1) stimulating endothelial nitric oxide synthase (eNOS) to increase cerebral blood flow via vasodilation; (2) scavenging reactive oxygen species to protect neuronal membranes; (3) modulating NF-κB inflammatory signalling to reduce neuroinflammation. Pycnogenol is a branded form.

Clinical evidence summary

Human effect matrix

Based on human clinical trials only. Animal and in-vitro data excluded.

Effect	Evidence	Magnitude	Studies	Notes
Attention & Focus	preliminary	Small	3	Two non-randomized studies from one author group (Belcaro 2014; Luzzi 2011) report improvements; the independent Cochrane review rates pine bark evidence as very low certainty.
Oxidative Stress Reduction	preliminary	Moderate	1	Plasma free radicals fell 30.4% (vs +0.9% in controls) over 12 weeks in Belcaro 2014; proanthocyanidin antioxidant activity is well established mechanistically.
Cerebral Blood Flow	moderate	Small	—	Proposed via eNOS stimulation and nitric oxide production; not re-verified in our 2026 review.
Memory	preliminary	Small	2	A non-randomized student study (Luzzi 2011) reported memory gains, and a 2025 network meta-analysis ranked Pycnogenol highly in mild cognitive impairment, with a caution about heterogeneous trials.

Evidence key: Strong = multiple consistent RCTs · Moderate = smaller/fewer RCTs · Preliminary = early trials or small n · Mixed = conflicting results

Documented benefits

Lower oxidative stress markers
Attention and focus (preliminary, non-randomized studies)
Antioxidant activity

Side effects & cautions

Generally well tolerated, though adverse-event reporting was inconsistent across trials (Cochrane 2020)
Rare: mild GI discomfort
Headache (uncommon)
Immunosuppressants: possible interaction, not confirmed by clinical reports — ask your doctor

How to take

Dosage100–200mg/day of standardised extract (65-75% proanthocyanidins)

TimingMorning with breakfast. Can be split into 2 doses for sustained antioxidant coverage.

With foodTake with food for better absorption and reduced GI risk. Fat is not required but a meal is recommended.

FormsCapsule is standard. Pycnogenol is a branded extract; it is the extract used in the studies we cite (Belcaro 2014; Luzzi 2011). Generic pine bark extracts vary widely in proanthocyanidin content — check standardisation percentage.

Stacking recommendations

Ingredients that pair well with Maritime Pine Bark Extract and why.

Citicoline

Citicoline provides cholinergic focus; Pine Bark provides blood flow and antioxidant support. Together they form the core of Performance Lab Mind — a minimal, evidence-based focus stack.

L-Tyrosine

Pine Bark supports cerebral blood flow (delivery); Tyrosine supports catecholamine synthesis (production). Complementary supply-side + demand-side pairing.

DHA (Omega-3)

Pine Bark protects neuronal membranes from oxidative damage; DHA provides the structural fatty acid for those membranes. Protective + structural combination.

Frequently asked questions

What is Pycnogenol and is it worth the premium?

Pycnogenol is a patented extract of French Maritime Pine Bark (Pinus pinaster) standardised to 65-75% proanthocyanidins with a specific manufacturing process. It is the extract used in the studies we cite (Belcaro 2014; Luzzi 2011); we found no trial comparing it with generic pine bark extract. Generic pine bark extracts may vary in composition. To match that evidence, choose Pycnogenol.

How does Maritime Pine Bark compare to Ginkgo Biloba?

Both improve cerebral blood flow but via different mechanisms: Ginkgo inhibits platelet-activating factor; Pine Bark stimulates nitric oxide. Pine Bark has stronger antioxidant activity; Ginkgo has a larger evidence base for cognitive decline. No trial has tested the combination, and ginkgo raises bleeding risk with blood thinners.

Can I take Pine Bark Extract long-term?

The pooled trials ran from 4 weeks to 6 months, and the Cochrane review notes adverse events were reported inconsistently, so the absence of reported harm is not proof of long-term safety. No cycling protocol has been tested. Check with your doctor if you take immunosuppressants.

Why is the dose in Performance Lab Mind only 75mg?

Performance Lab Mind uses 75mg Maritime Pine Bark — below the 100-200mg clinical dose on this page (the Belcaro 2014 study we cite used 150mg/day). It sits in a multi-ingredient formula with Citicoline and Tyrosine, but it is still underdosed relative to the standalone evidence.

Top stacks containing Maritime Pine Bark Extract

Mind Lab Pro

7.5/10

Performance Lab

Editor's Choice